COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,033 Articles (22,627 medRxiv, 8,406 bioRxiv)

Most recent first Previous |  Page 33: Articles 321-330  | Next

Targeting PI3K Signaling for Broad Inhibition of β-Coronavirus Infection
Xing, J., Wang, Q., Chen, N., Nutsford, A. N., Sullivan-Hill, B., Taylor, J. A., Rewcastle, G., Flanagan, J. U., Li, S., Shepherd, P. R., Yue, J., Netzler, N. E.
10.1101/2025.06.22.660949 — Posted: 2025-06-23
Olfactory, gustatory and trigeminal changes in non-hospitalized COVID-19 patients: an exploratory prospective cohort study.
van Elst, J. M., Tami, A., Vincenti-Gonzalez, M. F., Wold, K. I., Veloo, L. A., van der Gun, B. T., Jager-Wittenaar, H., Reyners, A. K. L., de Haan, J. J.
10.1101/2025.06.20.25329477 — Posted: 2025-06-22
Estimating Incidence of Respiratory Syncytial Virus- and Influenza Virus-Associated Hospitalizations with Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan During and After the COVID-19 Era: A Multicenter Active Surveillance Study (APSG-J2)
Maeda, H., Masuda, S., Dhoubhadel, B. G., Fujita, Y., Akiba, Y., Nishigaki, Y., Nakashima, K., Ito, H., Nogi, M., Otsuka, Y., Ishida, M., Takeuchi, E., Asoh, N., Sawai, T., Hayakawa, K., Dunne, E. M., Schwarz, C., Gessner, B. D., Ito, S., Igarashi, A., Osanai, S., Morimoto, K., Ariyoshi, K., Adult Pneumonia Study Group-Japan 2 (APSG-J2)
10.1101/2025.06.18.25329683 — Posted: 2025-06-20
Quantum-enhanced nanodiamond rapid test advances early SARS-CoV-2 antigen detection in clinical diagnostics
Thomas DeCruz, A., Miller, B. S., Huang, D., McRobbie, M., Donaldson, F., McCoy, L. E., O'Sullivan, C., Botha, J., Nastouli, E., McKendry, R. A.
10.1101/2025.06.19.25329920 — Posted: 2025-06-20
Effects of Pycnogenol(R) in post-COVID-19 condition (PYCNOVID): A single-center, placebo controlled, quadruple-blind, randomized trial
Kopp, J., Kuenzi, L., Rueegg, S., Braun, J., Rasi, M., Anagnostopoulos, A., Puhan, M. A., Fehr, J. S., Radtke, T.
10.1101/2025.06.12.25329489 — Posted: 2025-06-20
Observed-to-Expected Fetal Losses Following mRNA COVID-19 Vaccination in Early Pregnancy
Guetzkow, J., Patalon, T., Gazit, S., Hoeg, T. B., Fraiman, J., Segal, Y., Levi, R.
10.1101/2025.06.18.25329352 — Posted: 2025-06-20
Multimodal MRI Reveals Consistent Basal Ganglia and Limbic System Alterations in COVID-19 Survivors
Mishra, S. S., Pedersini, C., Misra, R., Yadav, P., Hafiz, R., Rokers, B., Biswal, B., Gandhi, T. K.
10.1101/2025.06.20.25329994 — Posted: 2025-06-20
Allergic asthma and Type-2 immunity reduce COVID-19 severity
Zheng, M.
10.1101/2025.06.16.25329662 — Posted: 2025-06-20
Uncovering the Pathophysiological Pattern of Expression from Integrated Analysis across Uniformly Processed RNA Sequencing COVID-19 Datasets
Cole, A., Fukuda, B., Dahlstrom, T. J., Hung, L.-H., Yeung, K. Y.
10.1101/2025.06.18.660454 — Posted: 2025-06-20
A Phase III Randomized Controlled Trial Assessing the Safety and Immunogenicity of Biological E's XBB 1.5 RBD Subunit COVID-19 Booster Vaccine in Individuals Aged 5 to 80 Years
Thuluva, S., Paradkar, V., Gunneri, S., Mogulla, R., Yerroju, V., Dhar, C., Ningaaiah, S., Panchakshari, M., Gillurkar, C. S., Narang, M., Kisan, S. S., Rao, A. V.
10.1101/2025.06.16.25329675 — Posted: 2025-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).